CSF pharmacokinetics of ceftazidime in neurosurgical patients with an external ventriculostomy.
In 11 neurosurgical patients (seven women, four men, aged 22-73 years) undergoing external ventriculostomy, serum and cerebrospinal fluid (CSF) pharmacokinetics of ceftazidime (CAZ) administered as a chemoprophylactic agent were evaluated. Concentrations of CAZ in CSF correlated significantly (p less than 0.05) with serum concentrations and with leucocyte counts in CSF. Peak concentrations in CSF (range 0-25.5 mg/l) exceeded the MIC90 of Staphylococcus species in two and of Pseudomonas and Enterobacter species in five of 11 patients. The MIC90 values of the other relevant bacteria causing CNS infections in these patients were surpassed in nine of 11 patients.
Fuhr
U
U
Abteilung für Klinische Pharmakologie, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main.
Harder
S
S
Häfner
S
S
Rosenthal
D
D
Lorenz
R
R
Staib
A H
AH
D000328:Adult; D000368:Aged; D001812:Blood-Brain Barrier; D002442:Ceftazidime / Q000134:cerebrospinal fluid* / Q000493:pharmacokinetics; D002555:Cerebrospinal Fluid / Q000166:cytology; D002557:Cerebrospinal Fluid Shunts; D005260:Female; D006801:Humans; D007700:Kinetics; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D014696:Ventriculostomy
D002442:Ceftazidime